because it usually isn’t detected until late in the disease. But a new blood test that uses two protein markers is showing promise for picking it up earlier, researchers report.
The blood test is still in the investigative stages. A new study, published in Science Translational Medicine, finds it works with an 87 percent sensitivity, meaning that’s how often it can correctly identify someone with stage 1 or 2 pancreatic cancer. It also had 98 percent specificity, meaning the ability to accurately rule out cancer in a person who doesn’t have it.
Read Full Article Here >>